Effect of pentoxyphilin for reduce of erythropoietin needs in hemodialysis patiente with anemia

Not Applicable

• Conditions: Ens stage renal disease.; End-stage renal disease

• Registration Number: IRCT201011102417N4
• Lead Sponsor: Vice Chancellor for Research, Isfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

patient’s satisfaction, hemodialysis for at least 1 month, hemoglobin concentration <10g/dL in at least 2 episode, Erythropoietin use =12000unit per week, no bleeding over past month, no infection resulting admission in past month, vitamin C use, 2 tablet 250mg per week
Exclusion criteria: drug intolerance, bleeding during the study, infection resulting admission

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum hemoglobin level. Timepoint: onset, monthly,end of study. Method of measurement: g/dL.;Serum albumin. Timepoint: onset, monthly, end of study. Method of measurement: g/dL.;Erythropoietin use. Timepoint: monthly. Method of measurement: International unit.

Secondary Outcome Measures

Name	Time	Method
Total iron binding capacity. Timepoint: Baseline, 3rd month, at the end of study. Method of measurement: µg/dL.;Serum Iron level. Timepoint: Baseline, 3rd month, at the end of study. Method of measurement: µg/dL.